News Novartis AG

Equities

NOVN

CH0012005267

Market Closed - Swiss Exchange Other stock markets 11:31:10 2024-05-10 am EDT			5-day change	1st Jan Change
92.32 ^CHF	+1.97%		+4.94%	+8.78%

05:13pm	Novartis’ Scemblix Gets Third US FDA Breakthrough Therapy Designation	MT
03:43pm	Novartis Gets FDA Breakthrough Therapy Designation for Scemblix	DJ

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Novartis’ Scemblix Gets Third US FDA Breakthrough Therapy Designation	11:13am	MT
Novartis Gets FDA Breakthrough Therapy Designation for Scemblix	09:43am	DJ
Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update	09:27am	AQ
NOVARTIS AG : UBS maintains a Buy rating	May. 06	ZD
Health Care Flat Amid Mixed Earnings -- Health Care Roundup	May. 02	DJ
Sector Update: Health Care Stocks Softer Late Afternoon	May. 02	MT
Sector Update: Health Care Stocks Retreat Thursday Afternoon	May. 02	MT
Top Midday Stories: Novo Nordisk, Linde Shares Fall Post-Earnings; Peloton Shares Plummet After Announcing Job Cuts, CEO Change; Exxon-Pioneer Deal Gets FTC Approval With One Caveat	May. 02	MT
News Highlights : Top Company News of the Day - Thursday at 11 AM ET	May. 02	DJ
Novartis AG to Acquire Mariana Oncology in Deal Valued Up to $1.75 Billion.	May. 02	MT
News Highlights : Top Company News of the Day - Thursday at 9 AM ET	May. 02	DJ
Novartis : enters agreement to acquire Mariana Oncology, strengthening radioligand therapy pipeline	May. 02	PU
Novartis: acquisition of US-based Mariana Oncology	May. 02	CF
Switzerland's Novartis to Buy US-based Mariana Oncology for $1 Billion Upfront	May. 02	MT
Novartis to Buy Mariana Oncology, Pay $1 Billion Upfront	May. 02	MT
Novartis AG to Acquire Mariana Oncology	May. 02	MT
Novartis AG to Acquire Mariana Oncology	May. 02	MT
Novartis to Buy Mariana Oncology for Up to $1.75 Billion in Boost to Radioligand Therapy Business	May. 02	DJ
Novartis to buy radiology specialist Mariana Oncology for $1 billion	May. 02	RE
Chimeric Therapeutics Appoints COO; Shares Rise 4%	May. 01	MT